InventisBio Co., Limited

688382.SS·Shanghai·Healthcare

Compare

14.45+0.60 (+4.33%)today

At close: Nov 5, 3:00 PM CST · May be delayed up to 15 min · CNY

Key statistics

Previous close13.85

Open13.77

Day range13.7614.75

52-week range11.8834.60

Off day high−2.03%

Off 52-week high−58.24%

Volume22.86M

Avg. volume (3M)15.98M

Market cap8.38B

EPS (TTM)-0.6600

Forward P/E-43.79

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)—

Shares outstanding579.61M

Short interest—

Earnings date—

Analyst target32.55

Profit margin0.00%

Against its peers

Compare in full ›

	688382.SS	9966.HK	SMZ1.F	1167.HK	8SJ.F	688177.SS
Market cap	8.38B	6.43B	11.09B	3.85B	1.84B	7.38B
P/E (TTM)	—	—	31.2	6.6	—	—
Forward P/E	-43.8	-21.0	—	-167.5	—	-26.2
Price/book	6.6	3.3	2.6	2.4	2.4	171.3
Dividend yield	—	—	2.90%	—	—	—
1-year change	−48.70%	−39.84%	−23.60%	−32.34%	−40.07%	−34.43%
Today	+4.33%	+1.68%	+1.45%	+3.58%	+1.70%	+2.95%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to InventisBio's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Alphamab Oncology9966.HK · Biotechnology	6.43B	6.655	+1.68%
Sino Biopharmaceutical LimitedSMZ1.F · Biotechnology	11.09B	0.6235	+1.45%
Jacobio Pharmaceuticals Group Co., Ltd.1167.HK · Biotechnology	3.85B	4.920	+3.58%
Shanghai Junshi Biosciences Co., Ltd.8SJ.F · Biotechnology	1.84B	1.7900	+1.70%
Bio-Thera Solutions, Ltd.688177.SS · Biotechnology	7.38B	17.82	+2.95%
BioDlink International Company Limited1875.HK · Biotechnology	2.56B	3.525	+5.54%
BeBetter Med Inc.688759.SS · Biotechnology	7.56B	16.79	+4.42%
Mabwell (Shanghai) Bioscience Co., Ltd.688062.SS · Biotechnology	10.13B	22.67	+5.29%

Other companies in Biotechnology, closest in size first.

Company	Mkt cap	Price	Today
Adimmune Corporation4142.TW · Taichung, Taiwan	7.00B	16.60	−2.35%
Axsome Therapeutics, Inc.AXSM · New York, NY	7.21B	137.00	−1.87%
China Resources Boya Bio-pharmaceutical Group Co.,Ltd300294.SZ · Fuzhou, China	7.26B	14.40	+0.84%
ALK-Abelló A/S4AJ0.F · Horsholm, Denmark	7.23B	32.60	−0.43%
Jiangxi Fushine Pharmaceutical Co., Ltd.300497.SZ · Jingdezhen, China	7.55B	14.02	+2.26%
Chiome Bioscience Inc.4583.T · Shibuya, Japan	6.73B	83.00	−2.35%
Kidswell Bio Corporation4584.T · Chuo, Japan	7.25B	146.00	−2.67%
Chengdu Easton Biopharmaceuticals Co., Ltd.688513.SS · Chengdu, China	7.48B	42.37	+3.34%

Healthcare companies of a similar market value (7.18B).

Company	Mkt cap	Price	Today
Renhe Pharmacy Co.,Ltd000650.SZ · Drug Manufacturers - Specialty & Generic	7.24B	5.17	+0.39%
Kilitch Drugs (India) LimitedKILITCH.NS · Drug Manufacturers - Specialty & Generic	7.29B	208.47	−0.21%
Adimmune Corporation4142.TW · Biotechnology	7.00B	16.60	−2.35%
Axsome Therapeutics, Inc.AXSM · Biotechnology	7.21B	137.00	−1.87%
Jiuzhitang Co., Ltd.000989.SZ · Drug Manufacturers - Specialty & Generic	7.34B	8.57	+1.66%
Nanjing Xinjiekou Department Store Co., Ltd.600682.SS · Medical Care Facilities	7.24B	5.38	+0.75%
Kyowa Kirin Co., Ltd.KY4.F · Drug Manufacturers - Specialty & Generic	7.59B	14.50	+6.62%
China Resources Boya Bio-pharmaceutical Group Co.,Ltd300294.SZ · Biotechnology	7.26B	14.40	+0.84%

Also based in Shanghai, China, then elsewhere in China.

Company	Mkt cap	Price	Today
Semiconductor Manufacturing International Corporation0981.HK · Shanghai, China	406.71B	47.500	+2.28%
Bank of Communications Co., Ltd.C4C.F · Shanghai, China	85.24B	0.9646	−0.62%
WuXi AppTec Co., Ltd.2359.HK · Shanghai, China	620.33B	204.400	+3.34%
Shanghai Pudong Development Bank Co., Ltd.600000.SS · Shanghai, China	328.73B	9.87	−2.18%
China Pacific Insurance (Group) Co., Ltd.2601.HK · Shanghai, China	271.29B	28.200	+1.73%
East Money Information Co.,Ltd.300059.SZ · Shanghai, China	300.31B	18.98	−1.15%
Guotai Haitong Securities Co., Ltd.2611.HK · Shanghai, China	236.82B	13.470	+1.05%
China CSSC Holdings Limited600150.SS · Shanghai, China	266.26B	35.38	−0.39%

The stocks whose daily moves over the past year went most closely with InventisBio's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
Mabwell (Shanghai) Bioscience Co., Ltd.688062.SS · Correlation 0.79	10.13B	22.67	+5.29%
Shenzhen Chipscreen Biosciences Co., Ltd.688321.SS · Correlation 0.68	9.47B	21.39	+2.84%
Chengdu Easton Biopharmaceuticals Co., Ltd.688513.SS · Correlation 0.65	7.48B	42.37	+3.34%
Shanghai Junshi Biosciences Co., Ltd.1877.HK · Correlation 0.65	16.34B	15.930	+1.53%
Bio-Thera Solutions, Ltd.688177.SS · Correlation 0.61	7.38B	17.82	+2.95%
Hansoh Pharmaceutical Group Company Limited3692.HK · Correlation 0.55	213.29B	35.180	+3.11%
Abbisko Cayman Limited2256.HK · Correlation 0.54	5.03B	7.020	+6.85%
Betta Pharmaceuticals Co., Ltd.300558.SZ · Correlation 0.53	20.76B	49.05	+1.62%

What visitors to InventisBio's page also look at.

Company	Mkt cap	Price	Today
JIANGSU YAHONG MEDITECH CO LTD688176.SS	6.69B	11.70	+4.46%
BETTA300558.SZ	20.76B	49.05	+1.62%
ALPHAMAB-B9966.HK	6.43B	6.655	+1.68%
SHENZHEN CHIPSCREEN BIOSCIENCES688321.SS	9.47B	21.39	+2.84%
ABBISKO-B2256.HK	5.03B	7.020	+6.85%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 688382.SS news ›

Securities.io·2d agoPositive

InventisBio Nomelcitinib Meets Phase III Endpoints in Plaque Psoriasis

At week 16, both nomelcitinib groups achieved PASI 90 in more than 70% of patients, significantly higher than the placebo group at p The registrational readout follows positive Phase 2 results the company announced on December 3, 2024.…

ORKA LLY JNJ INCY

BioPharma APAC·2d agoPositive

InventisBio’s Nomelcitinib Achieves Both Primary and Key Secondary Endpoints in Phase III Psoriasis Trial

BioPharma APAC - InventisBioâs Nomelcitinib Achieves Both Primary and Key Secondary Endpoints in Phase III Psoriasis Trial 03 November 2026 | Tuesday | News InventisBio Co., Ltd. announced t

JNJ ORKA IGA LLY

From the 4Search news index, newest first.

In the news

1mentions in 30 days

1with it in the headline

Positivesentiment

Most coverage from

securities.io1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

About

Profile ›

InventisBio Co., Limited, a clinical stage biotech company, focuses on areas of oncology, autoimmune diseases, and metabolic disorders to address unmet medical needs in China. Its product pipeline for the oncology therapeutic area include Befoternitib (BPI-D0316), which is in Phase III clinical trial for the non-small cell lung cancer (NSCLS) indications; Garsorasib (D-1553), which is in phase II and III clinical trials to treat NSCLS and colorectal cancer; Taragarestrant (D-0502), which is in phase III and II to t…

SectorHealthcare

IndustryBiotechnology

Chief executiveYaolin Wang

Employees182

HeadquartersShanghai, China

Websiteinventisbio.com

Analyst ratings

Analysis ›

Strong buy1 analysts

Strong buy 0
Buy 1
Hold 0
Sell 0
Strong sell 0

Wall Street analyst consensus. Not a recommendation.

Quarterly results

Financials ›

Revenue
Net income
Net margin −860.3% (Q2 '26)

Prices may be delayed up to 15 min. Not investment advice.

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance